Clinical trial
Prognosis After Revascularization Therapy in the Dijon Ischemic Stroke Evaluation Study
NCT02856074 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognosis After Revascularization Therapy in the Dijon Ischemic Stroke Evaluation Study
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 13, 2016
- Completion date
- June 1, 2020
- Enrollment
- 821 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.